MOTORE SANITÀ – Accesso regionale alle terapie innovative in Piemonte, il punto sul diabete | 29 maggio 2023 Share Post navigation Comparative effects of glucose-lowering medications on kidney outcomes in type 2 diabetes: the GRADE randomized clinical trialPrediabetes, intervening diabetes and subsequent risk of dementia: the Atherosclerosis Risk in Communities (ARIC) study
